On May 24, 2018, the “20th Shanghai International Biotechnology and Medicine Symposium-Symposium on New Drug Preclinical Research and IND Application Strategies” hosted by Medicilon officially came to an end at the Shanghai International Convention Center! This meeting was supported and recognized by more than two hundred colleagues in the biomedical industry. At the same time,Read more
Blog
By medicilon | Featured Stories | Comments are Closed | 29 May, 2018 |
By medicilon | Uncategorized | Comments are Closed | 28 February, 2017 |
Medicilon’s IND application service platform has an in-depth understanding of the regulatory and policy environment of China and the United States and its technical requirements for chemical drugs. It can provide domestic customers with CFDA IND declaration and USFDA IND/ANDA declaration services; it can provide foreign customers with CFDA IND /ANDA declaration service. The serviceRead more
By medicilon | Featured Stories | Comments are Closed | 31 March, 2015 |
On March 18, Medicilon and Korea Pharmaceutical Manufacturers Association (KPMA) held a CFDA IND seminar in Seoul, South Korea. The theme of this seminar is “Experience Sharing and Exchange on CFDA’s IND Application and Drug Development Collaboration”. About 130 medical experts and scientists from more than 50 companies participated in this seminar. Medicilon CEO Dr.Read more